Lygos is a pioneering sustainable specialty chemicals company, leading the world’s transition toward better, cleaner, and more sustainable products. Founded in 2011 and headquartered in the United States, they have built a proprietary and fully integrated platform of the most advanced technologies across synthetic biology, industrial chemistry, and application development to rapidly deliver market relevant solutions to some of the world’s biggest sustainability challenges. With a focus on Biotechnology and Clean Energy industries, Lygos has recently secured a substantial $160.00M Convertible Note investment on 18 April 2022, signaling a confidence in the company’s potential. This investment will likely fuel their pipeline of high-performing, innovative solutions, paving the way for generations of new sustainable products and solutions.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Convertible Note | $160.00M | - | 18 Apr 2022 | |
Series B | $5.00M | 1 | 29 Sep 2019 | |
Grant | $2.00M | 1 | US Department of Energy | 03 Jun 2019 |
Grant | $750.00K | 1 | 11 Mar 2019 | |
Series B | $10.00M | 1 | 23 Jan 2019 |
No recent news or press coverage available for Lygos.